SCH 503034 Jumps on the Fast Track
February 2, 2006
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development.
Schering Hepatitis Drug Gets Fast Track Status
Pharmaceutical Business Review Online
February 1, 2006
By Staff Writer
The FDA has agreed to review Schering-Plough's investigational oral hepatitis C drug on a fast track basis, potentially allowing the treatment to reach the market quicker.
The drug, named SCH 503034, is an orally active inhibitor of the hepatitis C virus (HCV) serine protease that inhibits HCV replication. This mechanism is distinct from those of current therapies, thus SCH 503034 represents a novel class of HCV inhibitor. The treatment is currently in phase II clinical development.
Fast track designation allows FDA to expedite review of drugs and biologics for serious or life-threatening conditions and which demonstrate the potential to address unmet medical needs. An important feature of fast track designation is that it emphasizes the critical nature of close, early communication between the FDA and the sponsor company to improve the efficiency of product development.
SCH 503034 has demonstrated potent antiviral activity and was well- tolerated, both as monotherapy and in combination with another of the company's products Peg-intron (peginterferon alfa-2b). In phase I clinical studies patients chronically infected with HCV genotype 1 who had not responded to previous therapy seemed to benefit from SCH 503034.
Based on the results of the phase I clinical program and extensive preclinical safety and pharmacology studies, Schering-Plough is conducting a large, randomized phase II dose-finding study involving 300 patients worldwide. This study is further evaluating the safety and efficacy of SCH 503034 in combination with Peg-intron.
Posted by Editors at February 2, 2006 12:30 PM
Requirements for using and reposting articles
Site Topics
Frequently Asked Questions
Some of our most commonly asked questions and our answers to them.
HCV Symptoms
You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.
Lab Tests
What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.
Hepatitis C Genotypes
Learn about Hepatitis C Genotypes and their variants.
Viral Load
Provides detailed information on how to analyze and interpret viral load numbers as well as a link to a convenient Viral Load Chart.
What is...?
Learn more about various Hepatitis C related topics, including HCV, Ascites, Biopsies, and much more.
HCV Medicines
Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.
Glossary
Commonly used medical terms and definitions.
Hepatitis C Doctors
A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.
Biopsy Info
A comprehensive resource of information relating to the liver biopsy.
Cirrhosis
Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.
Liver Cancer
Liver Cancer/Hepatocellular Carcinoma studies, info sheets, FAQs, and analysis.
Liver Disease Medicines
An exhaustive list of links to studies, info sheets, FAQs, and analysis of the various drugs used to treat liver disease.
Hep-Central Email List
Sign up to learn about advances and breakthroughs in Hepatitis C research, including information about medical and complementary treatments.
HCV Links
Convenient links to other sites external to Hepatitis-Central.
-
HCV Transmission
Information about the transmission of Hepatitis C.
HCV Natural Remedies
A number of herbal products useful in the management of liver disease.
HCV Books
Recommended reading for those interested in hepatitis information.
Hepatitis C Forum
A Bulletin Board for discussions on hepatitis, treatments, etc.
Hepatitis C Activism
An easy way to get involved in urging our government to do more for Hepatitis C awareness and treatment research.
Advertisement
